Eric A. Storch, PhD

  • 6Articles
  • 25.8KReads
  • 2013–2023Active
  • 30Collaborators
  • 381Citations

About

Eric A. Storch, PhD, is affiliated with the Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine in Houston, Texas. His publications from 2013 to 2023 cover topics including obsessive-compulsive and related disorders, child and adolescent psychiatry, cognition, depression, neurology, and psychotherapy. His work includes studies on treatment strategies for refractory obsessive-compulsive disorder, cognitive-behavioral therapy applications, and analyses of depressive symptom measures in youth. He has frequently collaborated with co-authors such as Alessandro S. De Nadai and Joseph F. McGuire.

Publications

JCP
A Comparison of 3 Scales for Measuring Adolescent Depression
Original Research

A Comparison of 3 Scales for Measuring Adolescent Depression

December 18, 2023

Three patient-reported outcomes—Patient Health Questionnaire for Adolescents, Quick Inventory of Depressive Symptomatology–Self-Report, and Very Quick Inventory of Depressive Symptomatology–Self-Report—can assess depressive symptom severity and change over time. Scores on...
, , , et al
JCP
Original Research

Cost-Effectiveness of Treatments for OCD in Adults

February 6, 2018

Clinicians often have little direction regarding optimal treatment options for obsessive-compulsive disorder (OCD). Read this article to learn the relative effectiveness of 7 strategies for treating OCD.
, , , et al
JCP
Meta-Analysis

d-Cycloserine in Exposure Therapy

February 22, 2017

While exposure-based cognitive-behavioral therapy is effective for anxiety disorders, many patients often experience inadequate results from this treatment. This meta-analysis examines whether d-Cycloserine as an adjunct to CBT might...
, , , et al
JCP
Commentary

What to Make of Misidentification Rates in Obsessive-Compulsive Disorder

June 24, 2015

JCP
Case Report

Cognitive-Behavioral Therapy for Misophonia

May 27, 2015

Read a case report on cognitive-behavioral therapy for Misophonia for two youth who met the criteria.
, ,
JCP
Original Research

Double-Blind, Placebo-Controlled, Pilot Trial of Paliperidone Augmentation in Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder

June 15, 2013

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe